LAMEA Cell Viability Assays Market Size, Share to 2022-2028

LAMEA Cell Viability Assays Market Size, Share & Industry Trends Analysis Report By Product, By End User, By Application (Stem Cell Research, Drug Discovery & Development, and Diagnostics), By Country and Growth Forecast, 2022 - 2028

Published Date: December-2022 | Number of Pages: 129 | Format: PDF | Report ID: KBV-12856

Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support


Get in-depth analysis of the COVID-19 impact on the LAMEA Cell Viability Assays Market

Market Report Description

The Latin America, Middle East and Africa Cell Viability Assays Market would witness market growth of 15.5% CAGR during the forecast period (2022-2028).

ATP (Adenosine triphosphate) cell viability is an assay used to measure cell viability since only viable cells can make ATP. Reagents with the CellTiter-Glo luminescent cell viability assay that contains detergent, luciferin substrate, and stabilized luciferase can be used to measure ATP. The detergent lyses viable cells, discharging ATP into the medium.

Luciferin is used by luciferase to create luminescence in the presence of ATP, which can be detected in a few minutes using a luminometer. The CellTiter-Glo 2.0 Assay is given as a single solution that decreases the reagent preparation time and allows storing it at room temperature, making implementation easier.

As these ATP assays don’t require lengthy incubation times to convert a substrate into a colored product, they usually work faster than other methods. In addition, they have wide linearity and excellent sensitivity, making them very suitable for high throughput applications with low cell numbers. They also have reduced risks of artifacts than other methods.

The Dubai Health Authority (DHA), a governing entity, is responsible for monitoring the Health System in the Emirates of Dubai. DHA was established in 2007 by the Prime Minister of Dubai. The Health Regulation Sector (HRS) of the DHA is responsible for licensing, monitoring, and regulating health facilities and the professionals related to healthcare.

The Brazil market dominated the LAMEA Cell Viability Assays Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $58.2 million by 2028. The Argentina market is experiencing a CAGR of 16.1% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 15.2% during (2022 - 2028).

Based on Product, the market is segmented into Consumables (Reagents & Assay Kits and Microplates) and Instruments (Spectrophotometer, Microscopy, Cell Imaging & Analysis System, Flow Cytometry, and Others). Based on Reagents & Assay Kits, the market is segmented into Luminometric Assays, Dye Exclusion Assays, Colorimetric Assays, and Fluorometric Assays. Based on End User, the market is segmented into Biopharmaceutical & Pharmaceutical Companies, CROs & CMOs, Academic & Research Institutes, and Diagnostic Labs. Based on Application, the market is segmented into Stem Cell Research, Drug Discovery & Development, and Diagnostics. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

Free Valuable Insights: The Global Cell Viability Assays Market is Predict to reach $2.5 Billion by 2028, at a CAGR of 9.7%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bio-Rad Laboratories Inc., Merck KGaA, Becton, Dickinson and Company, PerkinElmer Inc., Promega Corporation, Biotium, Creative Bioarray, and Abcam Plc.

Scope of the Study

Market Segments Covered in the Report:

By Product

  • Consumables
    • Reagents & Assay Kits
      • Luminometric Assays
      • Dye Exclusion Assays
      • Colorimetric Assays
      • Fluorometric Assays
    • Microplates
  • Instruments
    • Spectrophotometer
    • Microscopy
    • Cell Imaging & Analysis System
    • Flow Cytometry
    • Others

By End User

  • Biopharmaceutical & Pharmaceutical Companies
  • CROs & CMOs
  • Academic & Research Institutes
  • Diagnostic Labs

By Application

  • Stem Cell Research
  • Drug Discovery & Development
  • Diagnostics

By Country

  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Key Market Players

List of Companies Profiled in the Report:

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories Inc.
  • Merck KGaA
  • Becton, Dickinson and Company
  • PerkinElmer Inc.
  • Promega Corporation
  • Biotium
  • Creative Bioarray
  • Abcam Plc

Unique Offerings from KBV Research

  • Exhaustive coverage
  • The highest number of market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Related Reports:

Global Cell Viability Assays Market Report 2022-2028

North America Cell Viability Assays Market Report 2022-2028

Europe Cell Viability Assays Market Report 2022-2028

Asia Pacific Cell Viability Assays Market Report 2022-2028

Purchase Report


Special Pricing & Discounts

  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities